Kirr Marbach & Co. LLC IN lowered its position in Markel Co. (NYSE:MKL) by 6.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,152 shares of the insurance provider’s stock after selling 782 shares during the period. Markel comprises 2.6% of Kirr Marbach & Co. LLC IN’s investment portfolio, making the stock its 19th largest position. Kirr Marbach & Co. LLC IN owned approximately 0.09% of Markel worth $11,859,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the company. Westwood Holdings Group Inc. increased its stake in shares of Markel by 4.5% in the fourth quarter. Westwood Holdings Group Inc. now owns 15,915 shares of the insurance provider’s stock worth $14,395,000 after buying an additional 687 shares during the period. Motley Fool Wealth Management LLC increased its stake in Markel by 2.9% in the fourth quarter. Motley Fool Wealth Management LLC now owns 7,747 shares of the insurance provider’s stock valued at $7,007,000 after buying an additional 219 shares during the last quarter. West Oak Capital LLC increased its stake in Markel by 13.0% in the first quarter. West Oak Capital LLC now owns 130 shares of the insurance provider’s stock valued at $127,000 after buying an additional 15 shares during the last quarter. Citadel Advisors LLC increased its stake in Markel by 6.5% in the third quarter. Citadel Advisors LLC now owns 17,375 shares of the insurance provider’s stock valued at $16,137,000 after buying an additional 1,055 shares during the last quarter. Finally, Epoch Investment Partners Inc. increased its stake in Markel by 26.9% in the third quarter. Epoch Investment Partners Inc. now owns 37,856 shares of the insurance provider’s stock valued at $35,160,000 after buying an additional 8,026 shares during the last quarter. 75.10% of the stock is owned by institutional investors.
Markel Co. (NYSE:MKL) traded up 0.14% during mid-day trading on Thursday, hitting $967.28. The stock had a trading volume of 26,035 shares. The firm has a market cap of $13.50 billion, a PE ratio of 30.93 and a beta of 0.91. Markel Co. has a 12-month low of $811.05 and a 12-month high of $992.00. The company has a 50-day moving average of $971.63 and a 200-day moving average of $922.81.
Markel (NYSE:MKL) last released its quarterly earnings results on Wednesday, February 8th. The insurance provider reported $9.11 earnings per share for the quarter, beating the Zacks’ consensus estimate of $5.23 by $3.88. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.37 billion. Markel had a return on equity of 5.38% and a net margin of 8.12%. Analysts expect that Markel Co. will post $27.80 earnings per share for the current year.
WARNING: This piece of content was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.wkrb13.com/markets/2065491/markel-co-mkl-stake-cut-by-kirr-marbach-co-llc-in.html.
Several analysts have recently weighed in on MKL shares. Zacks Investment Research raised Markel from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 17th. Boenning Scattergood started coverage on Markel in a report on Thursday, March 2nd. They issued an “outperform” rating and a $1,050.00 target price for the company.
In other news, Vice Chairman Steven A. Markel sold 2,000 shares of Markel stock in a transaction that occurred on Thursday, February 23rd. The stock was sold at an average price of $971.39, for a total transaction of $1,942,780.00. Following the sale, the insider now owns 111,478 shares of the company’s stock, valued at $108,288,614.42. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 2.65% of the company’s stock.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Co. (NYSE:MKL).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2065491/markel-co-mkl-stake-cut-by-kirr-marbach-co-llc-in.html
Receive News & Ratings for Markel Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Co. and related companies with MarketBeat.com's FREE daily email newsletter.